MFGE8 and breast cancer: All these analyses show that the presence of lactadherin, both at the mRNA and protein levels, is associated with more aggressive subtypes in BC patients and cell lines, suggesting that it could be used as a biomarker of worse prognosis and as a therapeutic option in some BC patients.